These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1285 related items for PubMed ID: 15028555

  • 21. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth.
    Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR.
    Oncogene; 2004 Jul 29; 23(34):5853-7. PubMed ID: 15208673
    [Abstract] [Full Text] [Related]

  • 22. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
    Stein GH, Drullinger LF, Soulard A, Dulić V.
    Mol Cell Biol; 1999 Mar 29; 19(3):2109-17. PubMed ID: 10022898
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC, Teng CM, Lin SL, Chen YM, Tsai TJ, Hsieh BS.
    Eur J Pharmacol; 2005 Jul 04; 517(1-2):1-10. PubMed ID: 15950964
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.
    Mita MM, Mita A, Rowinsky EK.
    Cancer Biol Ther; 2003 Jul 04; 2(4 Suppl 1):S169-77. PubMed ID: 14508096
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation.
    Gäbele E, Reif S, Tsukada S, Bataller R, Yata Y, Morris T, Schrum LW, Brenner DA, Rippe RA.
    J Biol Chem; 2005 Apr 08; 280(14):13374-82. PubMed ID: 15677443
    [Abstract] [Full Text] [Related]

  • 33. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA, Zhang D, Choo CK, Eckert RL, Jacobberger JW.
    Exp Cell Res; 2000 Aug 25; 259(1):149-57. PubMed ID: 10942587
    [Abstract] [Full Text] [Related]

  • 34. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L, Glassford J, Lea NC, Thomas NS, Klaus GG, Lam EW.
    Oncogene; 2001 Nov 01; 20(50):7352-67. PubMed ID: 11704865
    [Abstract] [Full Text] [Related]

  • 35. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.
    Takuwa N, Fukui Y, Takuwa Y.
    Mol Cell Biol; 1999 Feb 01; 19(2):1346-58. PubMed ID: 9891068
    [Abstract] [Full Text] [Related]

  • 36. Cytokine-induced phosphoinositide 3-kinase activity promotes Cdk2 activation in factor-dependent hematopoietic cells.
    Henry MK, Nimbalkar D, Hohl RJ, Quelle FW.
    Exp Cell Res; 2004 Sep 10; 299(1):257-66. PubMed ID: 15302592
    [Abstract] [Full Text] [Related]

  • 37. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.
    Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250
    [Abstract] [Full Text] [Related]

  • 38. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
    Suh JM, Song JH, Kim DW, Kim H, Chung HK, Hwang JH, Kim JM, Hwang ES, Chung J, Han JH, Cho BY, Ro HK, Shong M.
    J Biol Chem; 2003 Jun 13; 278(24):21960-71. PubMed ID: 12668683
    [Abstract] [Full Text] [Related]

  • 39. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling.
    Skinner HD, Zheng JZ, Fang J, Agani F, Jiang BH.
    J Biol Chem; 2004 Oct 29; 279(44):45643-51. PubMed ID: 15337760
    [Abstract] [Full Text] [Related]

  • 40. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
    Zhong XS, Zheng JZ, Reed E, Jiang BH.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):471-80. PubMed ID: 15474452
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.